Covishield Safety Concerns Prompt Doctors’ Group to Call for Comprehensive Review of All Covid Vaccines
PTK Exclusive Report New Delhi : In light of AstraZeneca’s recent acknowledgment of rare blood clotting side effects associated with its COVID-19 vaccine, concerns over the safety of Covishield, produced by the Serum Institute of India, have intensified. Under the banner of the Awaken India Movement (AIM), a group of doctors convened a…